AzTrials
AzTrials

HypoxiaESMUSNCT04780724

Evaluation of SpO2 Measurement Using a Smartwatch

A study testing Hypoxic gas mixture, Hypercapnic and hypoxic gas mixture and SpO2 measurement in people with Hypoxia and Hypercapnia, run by Czech Technical University in Prague at 1 site in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to compare the measurement of peripheral blood oxygen saturation using a smartwatch with a medical-grade pulse oximeter. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Hypoxia, Hypercapnia
What is being tested?
Hypoxic gas mixture, Hypercapnic and hypoxic gas mixture and SpO2 measurement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteCzechia
Study dates
15 Feb 2021to 30 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy volunteers from the Czech Technical University

Who cannot join

  • pregnancy
  • severe cardiovascular conditions
  • severe asthma or other severe respiratory conditions
  • injury to the upper limbs or hands that could affect the peripheral perfusion
  • diabetes
  • hypotension or hypertension

Trial locations and contacts

1 site in 1 country.

Czechia1 site
  • Faculty of Biomedical Engineering, Czech Technical University in Prague

    Kladno, 27201

Other trials in Czechia

About this study

The aim of the study is to compare the measurement of peripheral blood oxygen saturation using a smartwatch with a medical-grade pulse oximeter.

Read the detailed description

Recently, wearables, like smartwatches, have been gaining new possibilities in monitoring biological signals and they are used for home monitoring of health conditions. The newest models of smartwatches even measure peripheral blood oxygen saturation (SpO2). The study aims to compare the measurement of peripheral blood oxygen saturation using the latest smartwatch with a medical-grade pulse oximeter under the condition of normobaric hypoxia. Healthy participants will breathe oxygen-reduced mixtures (the hypoxic gas mixture of 12% O2 and 88% N2 and the hypercapnic and hypoxic gas mixture of 12% O2, 5% CO2, and 83% N2), which will temporarily reduce their blood oxygen saturation. SpO2 measurements will be taken by hand from the watch and the pulse oximeter simultaneously. The agreement of the measurements of both devices will be evaluated.

Conditions
Hypoxia, Hypercapnia
Being tested
Hypoxic gas mixture, Hypercapnic and hypoxic gas mixture, SpO2 measurement
Keywords
SpO2, pulse oximetry, smartwatch
Medical subject headings
Hypoxia, Hypercapnia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypoxic gas mixtureOther

    Gas mixture of 12% O2 and 88% N2 for five minutes.

  • Hypercapnic and hypoxic gas mixtureOther

    Gas mixture of 12% O2, 5% CO2, and 88% N2 for five minutes.

  • SpO2 measurementOther

    Two SpO2 measuring devices are active simultaneously during measurement.

Study groups in NCT04780724
Study groupRoleWhat they receive
HypoxicExperimentalParticipants inhale ambient air, the hypoxic gas mixture, and ambient air.
Receives: Other: Hypoxic gas mixture; Other: SpO2 measurement
HypercapnicExperimentalParticipants inhale ambient air, the hypercapnic and hypoxic gas mixture, and the ambient air.
Receives: Other: Hypercapnic and hypoxic gas mixture; Other: SpO2 measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Similarity of SpO2 readings

    The agreement of SpO2 measurements of both monitoring devices will be evaluated.

    Measured: 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2021
  2. Study start15 Feb 2021
  3. Primary completion30 Mar 2021
  4. Study completion30 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
All participants go through all study arms, in random order. Two measuring devices are active simultaneously during measurement on each participant and their functioning is compared.
Masking
Single blind
Who is masked
Participant
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04780724
Sponsor's protocol ID
smartwatch21
Acronym
ESMUS
Status last verified
Jan 2022
First submitted
1 Mar 2021
Last updated
28 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rafl J, Kulhanek F, Kudrna P, Ort V, Roubik K. Response time of indirectly accessed gas exchange depends on measurement method. Biomed Tech (Berl). 2018 Nov 27;63(6):647-655. doi: 10.1515/bmt-2017-0070.

    PubMed 28802098
  • Lauterbach CJ, Romano PA, Greisler LA, Brindle RA, Ford KR, Kuennen MR. Accuracy and Reliability of Commercial Wrist-Worn Pulse Oximeter During Normobaric Hypoxia Exposure Under Resting Conditions. Res Q Exerc Sport. 2021 Sep;92(3):549-558. doi: 10.1080/02701367.2020.1759768. Epub 2020 Jul 7.

    PubMed 32633688
  • Rafl J, Bachman TE, Rafl-Huttova V, Walzel S, Rozanek M. Commercial smartwatch with pulse oximeter detects short-time hypoxemia as well as standard medical-grade device: Validation study. Digit Health. 2022 Oct 11;8:20552076221132127. doi: 10.1177/20552076221132127. eCollection 2022 Jan-Dec.

    PubMed 36249475

Questions about this trial

What is this clinical trial studying?

A study testing Hypoxic gas mixture, Hypercapnic and hypoxic gas mixture and SpO2 measurement in people with Hypoxia and Hypercapnia, run by Czech Technical University in Prague at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Similarity of SpO2 readings (time frame: 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04780724, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in